Cargando…
The Effects of Bazedoxifene on Bone, Glucose, and Lipid Metabolism in Postmenopausal Women With Type 2 Diabetes: An Exploratory Pilot Study
BACKGROUND: Selective estrogen receptor modulators (SERMs) decrease homocysteine and cross-linking of pentosidine and reduce low-density lipoprotein cholesterol (LDL-C), and they are expected to improve bone quality and atherosclerosis. Therefore, the potential effects of bazedoxifene on bone (bone...
Autores principales: | Yoshii, Taishi, Yamada, Masayo, Minami, Taichi, Tsunoda, Tetsuji, Sasaki, Mayuko, Kondo, Yoshinobu, Satoh, Shinobu, Terauchi, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554215/ https://www.ncbi.nlm.nih.gov/pubmed/26345606 http://dx.doi.org/10.14740/jocmr2278w |
Ejemplares similares
-
The Effects of Ramelteon on Glucose Metabolism and Sleep Quality in Type 2 Diabetic Patients With Insomnia: A Pilot Prospective Randomized Controlled Trial
por: Tsunoda, Tetsuji, et al.
Publicado: (2016) -
Predicting the ability of elderly diabetes patients to acquire the insulin self‐injection technique based on the number of animal names recalled
por: Minami, Taichi, et al.
Publicado: (2017) -
Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011) -
Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes
por: Kondo, Yoshinobu, et al.
Publicado: (2013)